Pro-and Anti-inflammatory Cytokines in Rheumatoid Arthritis
Open accessThe DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by the accumulation of inflammatory cells into the synovium and the destruction of joints. Cytokines are important regulators of the synovial inflammation. Some cytokines, such as tumour necrosis factor (TNF)-alpha and interleukin (IL)-1, function by promoting inflammatory responses and by inducing cartilage degradation. Other cytokines, such as IL-4, IL-10 and IL-13, function mainly as anti-inflammatory molecules. Although anti-inflammatory cytokines are present in rheumatoid joints, in progressive RA their levels obviously are too low to neutralize the deleterious effects of proinflammatory cytokines. Inhibiting the action of proinflammatory cytokines by using specific cytokine inhibitors or anti-inflammatory cytokines is the basis for new therapies currently tested in patients with RA. Promising results on the use of neutralizing anti-TNF-alpha monoclonal antibodies in the treatment of RA have been reported. The results from a trial using recombinant IL-10 in the treatment of patients with RA are available in the near future and will be important in determining the therapeutic potential of this cytokine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Dayer, J. M., Beutler, B., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.2163 · Cited by 1,216
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Punnonen, J., Aversa, G., Cocks, B. G., McKenzie, A. N., Menon, S., Zurawski, G., de Waal Malefyt, R., & de Vries, J. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3730 · Cited by 1,102
Self-citationTreatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Elliott, M. J., Maini, R. N., Feldmann, M., Long‐Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361206 · Cited by 1,038
An interleukin 1 like factor stimulates bone resorption in vitro
Gowen, M., Wood, D. D., Ihrie, E. J., McGuire, M. K. B., & Russell, R. G. G. (1983) · Nature · doi:10.1038/306378a0 · Cited by 1,012
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81109-5 · Cited by 970
Arend, W. P., & Dayer, J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380202 · Cited by 891
lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses
Minty, A., Chalon, P., Derocq, J.-M., Dumont, X., Guillemot, J.-C., Kaghad, M., Labit, C., Leplatois, P., Liauzun, P., Miloux, B., et al. (1993) · Nature · doi:10.1038/362248a0 · Cited by 871
Houssiau, F. A., Devogelaer, J., Damme, J. V., Deuxchaisnes, C. N. D., & Snick, J. V. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310614 · Cited by 847
Interleukin 10 protects mice from lethal endotoxemia.
Howard, M., Muchamuel, T., Andrade, S., & Menon, S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1205 · Cited by 792
Vieira, P., de Waal-Malefyt, R., Dang, M. N., Johnson, K. E., Kastelein, R., Fiorentino, D. F., deVries, J. E., Roncarolo, M. G., Mosmann, T. R., & Moore, K. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1172 · Cited by 739
de Waal Malefyt, R., Figdor, C. G., Huijbens, R., Mohan-Peterson, S., Bennett, B., Culpepper, J., Dang, W., Zurawski, G., & de Vries, J. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.6370 · Cited by 648
Dayer, J. M., de Rochemonteix, B., Burrus, B., Demczuk, S., & Dinarello, C. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112350 · Cited by 624
de Waal Malefyt, R., Yssel, H., & de Vries, J. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.11.4754 · Cited by 603
Chu, C. Q., Field, M., Feldmann, M., & Maini, R. N. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340908 · Cited by 578
Saxne, T., Palladino, M. A., Heinegãrd, D., Talal, N., & Wollheim, F. A. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310816 · Cited by 566
How important are t cells in chronic rheumatoid synovitis?
Firestein, G. S., & Zvaifler, N. J. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330602 · Cited by 540
Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
Katsikis, P. D., Chu, C. Q., Brennan, F. M., Maini, R. N., & Feldmann, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1517 · Cited by 529
Guerne, P. A., Zuraw, B. L., Vaughan, J. H., Carson, D. A., & Lotz, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113921 · Cited by 513
McInnes, I. B., Leung, B. P., Sturrock, R. D., Field, M., & Liew, F. Y. (1997) · Nature Medicine · doi:10.1038/nm0297-189 · Cited by 512
(2008) · Arthritis & Rheumatism · doi:10.1002/art.23363 · Cited by 505
Pettipher, E. R., Higgs, G. A., & Henderson, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.22.8749 · Cited by 496
IL-10 inhibits human T cell proliferation and IL-2 production
Taga, K., & Tosato, G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.4.1143 · Cited by 482
The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritis
McInnes, I. B., Al-Mughales, J., Field, M., Leung, B. P., Huang, F.-P., Dixon, R., Sturrock, R. D., Wilkinson, P. C., & Liew, F. Y. (1996) · Nature Medicine · doi:10.1038/nm0296-175 · Cited by 477
Panayi, G. S., Lanchbury, J. S., & Kingsley, G. H. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350702 · Cited by 461
te Velde, A., Huijbens, R., Heije, K., de Vries, J., & Figdor, C. (1990) · Blood · doi:10.1182/blood.v76.7.1392.1392 · Cited by 449
Inflammatory and immunomodulatory roles of TGF-β
Wahl, S. M., McCartney-Francis, N., & Mergenhagen, S. E. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90136-9 · Cited by 449
Chernoff, A. E., Granowitz, E. V., Shapiro, L., Vannier, E., Lonnemann, G., Angel, J. B., Kennedy, J. S., Rabson, A. R., Wolff, S. M., & Dinarello, C. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5492 · Cited by 418
IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells
Yssel, H., De Waal Malefyt, R., Roncarolo, M. G., Abrams, J. S., Lahesmaa, R., Spits, H., & de Vries, J. E. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.7.2378 · Cited by 406
Joosten, L. A. B., Helsen, M. M. A., van de Loo, F. A. J., & van den Berg, W. B. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390513 · Cited by 400
Joosten, L. A. B., Lubberts, E., Durez, P., Helsen, M. M. A., Jacobs, M. J. M., Goldman, M., & van den Berg, W. B. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400209 · Cited by 397
Divergent T-cell cytokine patterns in inflammatory arthritis.
Simon, A. K., Seipelt, E., & Sieper, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8562 · Cited by 377
Cope, A. P., Gibbons, D., Brennan, F. M., Feldmann, M., Aderka, D., Doherty, M., Jones, A. C., Engelmann, H., Wallach, D., & Maini, R. N. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351008 · Cited by 337
Buchan, G. S., Barrett, K., Turner, M., Chantry, D., Maini, R. N., & Feldmann, M. (1988) · PubMed Central · Cited by 332
Llorente, L., Richaud‐Patin, Y., Fior, R., Alcocer‐Varela, J., Wijdenes, J., Fourrier, B. M., Galanaud, P., & Emilie, D. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371114 · Cited by 313
Haworth, C., Brennan, F. M., Chantry, D., Turner, M., Maini, R. N., & Feldmann, M. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211039 · Cited by 299
Kasama, T., Strieter, R. M., Lukacs, N. W., Lincoln, P. M., Burdick, M. D., & Kunkel, S. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117993 · Cited by 270
Sornasse, T., Larenas, P. V., Davis, K. A., de Vries, J. E., & Yssel, H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.473 · Cited by 269
Interleukin‐10 inhibition of the progression of established collagen‐induced arthritis
Walmsley, M., Katsikis, P. D., Abney, E., Parry, S., Williams, R. O., Maini, R. N., & Feldmann, M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390318 · Cited by 261
Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta.
Allen, J. B., Manthey, C. L., Hand, A. R., Ohura, K., Ellingsworth, L., & Wahl, S. M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.1.231 · Cited by 258
Elevated interleukin-10 levels in patients with rheumatoid arthritis: ELEVATED IL-10 RA PATIENTS
Cush, J. J., Splawski, J. B., Thomas, R., Mcfarlin, J. E., Schulze-Koops, H., Davis, L. S., Fujita, K., & Lipsky, P. E. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380115 · Cited by 249
Campion, G. V., Lebsack, M. E., Lookabaugh, J., & Gordon, G. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390704 · Cited by 247
Firestein, G. S., Xu, W. D., Townsend, K., Broide, D., Alvaro-Gracia, J., Glasebrook, A., & Zvaifler, N. J. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.5.1573 · Cited by 247
RANKIN, E. C. C., CHOY, E. H. S., KASSIMOS, D., KINGSLEY, G. H., SOPWTTH, A. M., ISENBERG, D. A., & PANAYI, G. S. (1995) · Rheumatology · doi:10.1093/rheumatology/34.4.334 · Cited by 231
CHU, C. Q., FIELD, M., ALLARD, S., ABNEY, E., FELDMANN, M., & MAINI, R. N. (1992) · Rheumatology · doi:10.1093/rheumatology/31.10.653 · Cited by 229
Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals.
Brandes, M. E., Allen, J. B., Ogawa, Y., & Wahl, S. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115073 · Cited by 220
Onoe, Y., Miyaura, C., Kaminakayashiki, T., Nagai, Y., Noguchi, K., Chen, Q. R., Seo, H., Ohta, H., Nozawa, S., Kudo, I., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.2.758 · Cited by 211
Synovial interleukin‐1 receptor antagonist and interleukin‐1 balance in rheumatoid arthritis
Firestein, G. S., Boyle, D. L., Yu, C., Paine, M. M., Whisenand, T. D., Zvaifler, N. J., & Arend, W. P. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370507 · Cited by 210
Alvaro-Gracia, J. M., Zvaifler, N. J., Brown, C. B., Kaushansky, K., & Firestein, G. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3365 · Cited by 204
Biphasic effect of interferon‐γ in murine collagen‐induced arthritis
Boissier, M., Chiocchia, G., Bessis, N., Hajnal, J., Garotta, G., Nicoletti, F., & Fournier, C. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250508 · Cited by 203
Germann, T., Szeliga, J., Hess, H., Störkel, S., Podlaski, F. J., Gately, M. K., Schmitt, E., & Rüde, E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4823 · Cited by 198
Chomarat, P., Vannier, E., Dechanet, J., Rissoan, M. C., Banchereau, J., Dinarello, C. A., & Miossec, P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1432 · Cited by 194
Miossec, P., Briolay, J., Dechanet, J., Wijdenes, J., Martinez‐Valdez, H., & Banchereau, J. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350805 · Cited by 185
DELEURAN, B. W., CHU, C. Q., FIELD, M., BRENNAN, F. M., KATSIKIS, P., FELDMANN, M., & MAINI, R. N. (1992) · Rheumatology · doi:10.1093/rheumatology/31.12.801 · Cited by 183
Low levels of interleukin‐4 and high levels of transforming growth factor β in rheumatoid synovitis
Miossec, P., Naviliat, M., D'Angeac, A. D., Sany, J., & Banchereau, J. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330819 · Cited by 180
Lacraz, S., Isler, P., Vey, E., Welgus, H. G., & Dayer, J. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31750-7 · Cited by 177
van Roon, J. A. G., van Roy, J. L. A. M., Gmelig‐Meyling, F. H. J., Lafeber, F. P. J. G., & Bijlsma, J. W. J. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390516 · Cited by 176
Firestein, G. S., & Zvaifler, N. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300804 · Cited by 175
Ulfgren, A. K., Lindblad, S., Klareskog, L., Andersson, J., & Andersson, U. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.8.654 · Cited by 173
Allen, J. B., Wong, H. L., Costa, G. L., Bienkowski, M. J., & Wahl, S. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.8.4344 · Cited by 168
Alvaro-Gracia, J. M., Zvaifler, N. J., & Firestein, G. S. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.865 · Cited by 162
Lorenz, H., Antoni, C., Valerius, T., Repp, R., Grünke, M., Schwerdtner, N., Nüßlein, H. G., Woody, J. N., Kalden, J. R., & Manger, B. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.4.1646 · Cited by 160
Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta.
Wahl, S. M., Allen, J. B., Costa, G. L., Wong, H. L., & Dasch, J. R. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.1.225 · Cited by 155
In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice.
Hom, J. T., Bendele, A. M., & Carlson, D. G. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.834 · Cited by 154
Interleukin‐10 functions as an antiinflammatory cytokine in rheumatoid synovium
Isomäki, P., Luukkainen, R., Saario, R., Toivanen, P., & Punnonen, J. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390306 · Cited by 146
Self-citationMalefyt, R. D. W., Abrams, J. S., Zurawski, S. M., Lecron, J.-C., Mohan-Peterson, S., Sanjanwala, B., Bennett, B., Silver, J., de Vries, J. E., & Yssel, H. (1995) · International Immunology · doi:10.1093/intimm/7.9.1405 · Cited by 143
QUAYLE, A. J., CHOMARAT, P., MIOSSEC, P., KJELDSEN‐KRAGH, J., FØRRE, Ø., & NATVIG, J. B. (1993) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1993.tb01696.x · Cited by 131
Firestein, G. S., Berger, A. E., Tracey, D. E., Chosay, J. G., Chapman, D. L., Paine, M. M., Yu, C., & Zvaifler, N. J. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.3.1054 · Cited by 128
Bucht, A., Larsson, P., Weisbrot, L., Thorne, C., Pisa, P., Smedegård, G., Keystone, E. C., & Grönberg, A. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1996.tb08288.x · Cited by 125
IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells.
Punnonen, J., & de Vries, J. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.3.1094 · Cited by 123
Self-citationCannon, G. W., Pincus, S. H., Emkey, R. D., Denes, A., Cohen, S. A., Wolfe, F., Anthony Saway, P., Jaffer, A. M., Weaver, A. L., Cogen, L., et al. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320805 · Cited by 111
Miossec, P., Chomarat, P., Dechanet, J., Moreau, J., Roux, J., Delmas, P., & Banchereau, J. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371202 · Cited by 111
Isomäki, P., Luukkainen, R., Toivanen, P., & Punnonen, J. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391012 · Cited by 110
Self-citationCampbell, I. K., Piccoli, D. S., Roberts, M. J., Muirden, K. D., & Hamilton, J. A. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330412 · Cited by 105
Drevlow, B. E., Lovis, R., Haag, M. A., Sinacore, J. M., Jacobs, C., Blosche, C., Landay, A., Moreland, L. W., & Pope, R. M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390212 · Cited by 103
Transforming growth factor-β1 in rheumatoid synovial membrane and cartilage pannus junction
CHU, C. Q., FIELD, M., ABNEY, E., ZHENG, R. Q. H., ALLARD, S., FELDMANN, M., & MAINI, R. N. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1991.tb02941.x · Cited by 94
IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures
Wernick, R. M., Lipsky, P. E., Marban-arcos, E., Maliakkal, J. J., Edelbaum, D., & Ziff, M. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280704 · Cited by 94
Hamilton, J. A. (1993) · The Lancet · doi:10.1016/0140-6736(93)91653-4 · Cited by 92
Wong, H. L., Costa, G. L., Lotze, M. T., & Wahl, S. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.3.775 · Cited by 88
VEYS, E. M., Menkès, C.-J., & Emery, P. E. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400110 · Cited by 78
Hess, H., Gately, M. K., Rüde, E., Schmitt, E., Szeliga, J., & Germann, T. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260129 · Cited by 56
Brennan, F. M., Gibbons, D. L., Cope, A. P., Katsikis, P. D., Maini, R. N., & Feldmann, M. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03639.x · Cited by 51
Perez, L., Orte, J., & Brieva, J. A. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381210 · Cited by 45
Aetiopathogenesis of Rheumatoid Arthritis
Maini, R. N., Chu, C., & Feldmann, M. (1995) · Elsevier eBooks · doi:10.1016/b978-012340440-4/50034-9 · Cited by 12
Cited by
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
Choy, E. H. S., & Panayi, G. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441207 · Cited by 2,249
Tumor Necrosis Factor-α Signaling in Macrophages
Parameswaran, N., & Patial, S. (2010) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v20.i2.10 · Cited by 1,437
Lecaille, F., Kaleta, J., & Brömme, D. (2002) · Chemical Reviews · doi:10.1021/cr0101656 · Cited by 519
Zhang, Y.-H., Heulsmann, A., Tondravi, M. M., Mukherjee, A., & Abu-Amer, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008198200 · Cited by 498
Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis
Mateen, S., Zafar, A., Moin, S., Khan, A. Q., & Zubair, S. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.02.010 · Cited by 418
Metadata
- Authors
- Isomäki, P., & Punnonen, J.
- Venue
- Annals of Medicine
- Publisher
- Informa UK Limited
- Published
- 1997-01
- Volume
- 29
- Issue
- 6
- Pages
- 499-507
- ISSN
- 0785-3890 (ISSN-L)
- 1365-2060
- OpenAlex
- W2140611998
- Cited by
- 260
- References
- 93
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.